Differentials

Obstructive bile duct lesion

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Previous history of bile duct surgery/obstruction.

Pain is much more prominent than with PBC.

Bacterial cholangitis as a complication is much more likely than in PBC.

INVESTIGATIONS

Antimitochondrial antibody or disease-specific antinuclear antibody not associated.

Abdominal ultrasound finding of duct dilatation (confirmed by magnetic resonance cholangiopancreatography [MRCP] or endoscopic retrograde cholangiopancreatography [ERCP] according to local practice) confirmatory.

Small-duct primary sclerosing cholangitis

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Different demographics than PBC (primary sclerosing cholangitis [PSC] is more common in younger males).

Association with inflammatory bowel disease.

INVESTIGATIONS

Antimitochondrial antibody or disease-specific antinuclear antibody not associated.

Perinuclear antineutrophil cytoplasmic antibody (p-ANCA) suggestive of PSC may be present. This marker is absent in the majority of patients with PBC.

Abdominal ultrasound finding of duct irregularity (confirmed by magnetic resonance cholangiopancreatography [MRCP] or endoscopic retrograde cholangiopancreatography [ERCP] according to local practice) is confirmatory.

Liver biopsy characteristic of PSC.

Drug-induced cholestasis

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

History of relevant drug exposure. Can also occur as a consequence of exposure to herbal/nonpharmaceutical preparations.

INVESTIGATIONS

Antimitochondrial antibody or disease-specific antinuclear antibody not associated.

Liver biopsy characteristic of cholestasis.

Cholestasis of pregnancy

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Associated with pregnancy.

INVESTIGATIONS

Antimitochondrial antibody or disease-specific antinuclear antibody not associated.

Bile acids elevated, transaminases more prominent than alkaline phosphatases.

Infiltrative malignancy within liver

SIGNS / SYMPTOMS
INVESTIGATIONS
SIGNS / SYMPTOMS

Associated with other systemic features suggestive of malignant disease.

INVESTIGATIONS

Cross-sectional imaging.

Liver biopsy if doubt persists.

Use of this content is subject to our disclaimer